BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30074068)

  • 1. Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study.
    Sansone A; De Rosa N; Giampaolino P; Guida M; Laganà AS; Di Carlo C
    Arch Gynecol Obstet; 2018 Oct; 298(4):731-736. PubMed ID: 30074068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
    Niu X; Luo Q; Wang C; Zhu L; Huang L
    Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review.
    Ambacher K; Secter M; Sanders AP
    Curr Med Res Opin; 2022 Mar; 38(3):479-486. PubMed ID: 35048754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
    Ferrero S; Scala C; Ciccarelli S; Vellone VG; Barra F
    Gynecol Endocrinol; 2020 Jun; 36(6):540-544. PubMed ID: 31711348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
    Margatho D; Carvalho NM; Bahamondes L
    Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):133-140. PubMed ID: 32069126
    [No Abstract]   [Full Text] [Related]  

  • 7. Women with deep infiltrating endometriosis: sexual satisfaction, desire, orgasm, and pelvic problem interference with sex.
    Montanari G; Di Donato N; Benfenati A; Giovanardi G; Zannoni L; Vicenzi C; Solfrini S; Mignemi G; Villa G; Mabrouk M; Schioppa C; Venturoli S; Seracchioli R
    J Sex Med; 2013 Jun; 10(6):1559-66. PubMed ID: 23551753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
    Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
    J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.
    Caruso S; Iraci M; Cianci S; Casella E; Fava V; Cianci A
    J Endocrinol Invest; 2015 Nov; 38(11):1211-8. PubMed ID: 26337183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual functioning, quality of life and pelvic pain 12 months after endometriosis surgery including vaginal resection.
    Setälä M; Härkki P; Matomäki J; Mäkinen J; Kössi J
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):692-8. PubMed ID: 22404128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?
    Caruso S; Cianci A; Iraci M; Fava V; Di Pasqua S; Cianci S
    J Womens Health (Larchmt); 2020 Sep; 29(9):1184-1191. PubMed ID: 32678691
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
    Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
    Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
    Margatho D; Mota Carvalho N; Eloy L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):344-350. PubMed ID: 30372645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid.
    Caruso S; Iraci Sareri M; Casella E; Ventura B; Fava V; Cianci A
    Minerva Ginecol; 2015 Oct; 67(5):413-9. PubMed ID: 26491823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study.
    Di Carlo C; Sansone A; De Rosa N; Gargano V; Tommaselli GA; Nappi C; Bifulco G
    Gynecol Endocrinol; 2014 Jan; 30(1):53-6. PubMed ID: 24131079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials.
    Pokrzywinski RM; Soliman AM; Chen J; Snabes MC; Coyne KS; Surrey ES; Taylor HS
    Am J Obstet Gynecol; 2020 Jun; 222(6):592.e1-592.e10. PubMed ID: 31759891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sexual function in women with deep infiltrating endometriosis.
    Cozzolino M; Magro-Malosso ER; Tofani L; Coccia ME
    Sex Reprod Healthc; 2018 Jun; 16():6-9. PubMed ID: 29804777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up.
    Carrillo Torres P; Martínez-Zamora MÁ; Ros C; Rius M; Mensión E; Gracia M; Carmona F
    Sci Rep; 2023 Feb; 13(1):2066. PubMed ID: 36739298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of endometriosis on sexual function as assessed with the Female Sexual Function Index: systematic review and meta-analysis.
    Pérez-López FR; Ornat L; Pérez-Roncero GR; López-Baena MT; Sánchez-Prieto M; Chedraui P
    Gynecol Endocrinol; 2020 Nov; 36(11):1015-1023. PubMed ID: 32880200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.